Table 2.
Comparison of patients’ demographic background in the remission and the non-remission groups by univariate analysis
| Measurements | Remission group (n = 23) | Non-remission group (n = 20) | P-value |
|---|---|---|---|
| Age, year |
39.2 ± 13.6 |
44.1 ± 16.2 |
ns |
| CAI score |
8.9 ± 2.1 |
9.3 ± 2.3 |
ns |
| Duration of UC (year) |
6.1 ± 7.3 |
8.6 ± 6.8 |
0.036 |
| Interval between relapse and the 1st GMA (day) |
27.7 ± 31.0 |
76.2 ± 88.1 |
0.016 |
| PSL at the 1st GMA (mg/day) |
18.7 ± 14.4 |
17.8 ± 10.5 |
ns |
| Cumulative PSL dose before 1st GMA (mg) |
939.2 ± 1125.9 |
4578.5 ± 4752.6 |
0.006 |
| WBC at the 1st GMA (/ul) |
8304.1 ± 2432.3 |
9572.9 ± 2283.4 |
0.032 |
| Hb at the 1st GMA (g/dl) |
12.0 ± 1.7 |
12.7 ± 2.0 |
ns |
| CRP at the 1st GMA (mg/dl) | 0.7 ± 1.0 | 0.7 ± 0.8 | ns |
CAI, clinical activity index; CRP, C-reactive protein; GMA, granulocyte and monocte apheresis; Hb, haemoglobin; WBC, white blood cell; ns, not significant (p > 0.05).